Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$57.92 - $72.58 $2.61 Million - $3.27 Million
-45,000 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$67.69 - $73.03 $3.05 Million - $3.29 Million
-45,000 Reduced 50.0%
45,000 $3.14 Million
Q4 2020

Feb 16, 2021

BUY
$56.65 - $64.55 $2.83 Million - $3.23 Million
50,000 Added 125.0%
90,000 $5.24 Million
Q3 2020

Nov 16, 2020

BUY
$62.1 - $78.08 $1.24 Million - $1.56 Million
20,000 Added 100.0%
40,000 $2.53 Million
Q2 2020

Aug 14, 2020

BUY
$72.34 - $84.0 $1.45 Million - $1.68 Million
20,000 New
20,000 $1.54 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $111B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Altrinsic Global Advisors LLC Portfolio

Follow Altrinsic Global Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altrinsic Global Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Altrinsic Global Advisors LLC with notifications on news.